Who
Arnold A. Pinkston
Director
Company insider
Files Form 4 as: Director, Bio-Rad Laboratories; CLO & Corporate Secretary, Corelogic; Director, Janus Capital Group; EVP and General Counsel, Allergan; SVP, Gen Counsel & Secretary, Beckman Coulter.
In numbers
- Trades disclosed
- 166
- Buys
- 0
- Sells
- 4
- Bought
- $0
- Sold
- $448K
- Companies
- 5
- Companies where not an officer
- 2
- First trade
- 4 Jan 2007
- Last trade
- 21 Apr 2026
- Last filed
- 23 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 Apr 2026filed 23 Apr 2026 | BIO Bio-Rad LaboratoriesLife-science tools | SEC FORM 4 Code M | —407 at $0.00 | filing |
| 21 Apr 2026filed 23 Apr 2026 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code A | —369 at $0.00 | filing |
| 21 Apr 2026filed 23 Apr 2026 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code M | —407 at $0.00 | filing |
| 21 Apr 2026filed 23 Apr 2026 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code A | —369 at $0.00 | filing |
| 21 Apr 2026filed 23 Apr 2026 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code M | —407 at $0.00 | filing |
| 21 Apr 2026filed 23 Apr 2026 | BIO Bio-Rad LaboratoriesLife-science tools | SEC FORM 4 Code M | —407 at $0.00 | filing |
| 22 Apr 2025filed 24 Apr 2025 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code A | —407 at $0.00 | filing |
| 22 Apr 2025filed 24 Apr 2025 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code M | —308 at $0.00 | filing |
| 22 Apr 2025filed 24 Apr 2025 | BIO Bio-Rad LaboratoriesLife-science tools | SEC FORM 4 Code M | —308 at $0.00 | filing |
| 6 Sep 2024filed 10 Sep 2024 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code A | —308 at $0.00 | filing |
| 4 Mar 2019filed 6 Mar 2019 | Corelogic | SEC FORM 4 Code A | —4,033 at $0.00 | filing |
| 1 Mar 2019filed 5 Mar 2019 | Corelogic | SEC FORM 4 Code A | —11,968 at $0.00 | filing |
| 1 Mar 2019filed 5 Mar 2019 | Corelogic | SEC FORM 4 Code F | —1,176 at $0.00 | filing |
| 5 Mar 2018filed 5 Mar 2018 | Corelogic | SEC FORM 4 Code A | —9,336 at $0.00 | filing |
| 30 May 2017filed 1 Jun 2017 | Janus Capital Group | SEC FORM 4 Code D | —8,717 | filing |
| 2 May 2016filed 4 May 2016 | Janus Capital Group | SEC FORM 4 Code A | —8,717 at $0.00 | filing |
| 17 Mar 2015filed 19 Mar 2015 | Allergan | SEC FORM 4 Code A | —6,341.5 at $0.00 | filing |
| 17 Mar 2015filed 19 Mar 2015 | Allergan | SEC FORM 4 Code D | —6,341.5 | filing |
| 17 Mar 2015filed 19 Mar 2015 | Allerganoption or derivative | SEC FORM 4 Code D | —18,000 | filing |
| 17 Mar 2015filed 19 Mar 2015 | Allerganoption or derivative | SEC FORM 4 Code D | —35,000 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.